Affiliation:
1. Digestion Internal Medicine Department, Xijing Hospital The First Affiliated Hospital of the Fourth Military Medical University Xi’an Shaanxi 710000, China
Abstract
Abstract
The purpose of this study was to compare the efficacy of nucleoside analogues (NAs) in the treatment of HBV-related liver failure. The data of patients with HBV-related liver failure treated with nucleoside analogues were used to conduct a network meta-analysis. A total of 1660 patients from 12 articles about the efficacy of lamivudine, entecavir, telbivudine and tenofovir for HBV-related liver failure treatment were recruited in the study. The highest two- and three-month survival rate was recorded for patients using tenofovir. The end-stage liver disease (MELD) score and mortality in patients undergoing tenofovir treatment were the lowest. Patients treated with telbivudine had the highest one-month survival rate. Patients receiving enticavir therapy showed the lowest HBV DNA level. Our results indicate that tenofovir may be the best therapy for the treatment of HBV-related liver failure compared to other nucleoside analogues (including lamivudine, entecavir and telbivudine) and non-NAs treatment.
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference32 articles.
1. 1. Y. Zhijian, L. Hui, Y. Weiming, L. Zhanzhou, C. Zhong, Z. Jinxin, W. Hongyan, D. Xiangbin, Y. Weizhi, L. Duoyun, L. Xiaojun and D. Qiwen, Role of the aspartate transaminase and platelet ratio index in assessing hepatic fibrosis and liver inflammation in adolescent patients with HBeAg-positive chronic hepatitis B, Gastroenterol. Res. Pract. 2015 (2015) Article ID 906026 (6 pages); https://doi.org/10.1155/2015/90602610.1155/2015/906026
2. 2. Q. Zhou and H. Tang, The progress of antiviral therapy in patients with HBV-related liver failure, Hepatogastroenterology 60 (2013) 1877-1880.
3. 3. S. Locarnini, Molecular virology of hepatitis B virus, Semin. Liver Dis. 24 (Suppl 1) (2004) 3-10.10.1055/s-2004-828672
4. 4. Y. F. Liaw, Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy, Antivir. Ther. 11 (2006) 669-679.
5. 5. Y. N. Ye and Z. L. Gao, Three attacks in the development of HBV-related liver failure, Infect. Dis. Inf. 22 (2009) 276-279; https://doi.org/10.3969/j.issn.1007-8134.2009.05.006
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献